2,4,4-TRIMETHYL-1,6-HEXANEDIAMINE
General Information
Mainterm | 2,4,4-TRIMETHYL-1,6-HEXANEDIAMINE |
CAS Reg.No.(or other ID) | 3236-54-2 |
Regnum |
177.1500 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 76714 |
IUPAC Name | 2,4,4-trimethylhexane-1,6-diamine |
InChI | InChI=1S/C9H22N2/c1-8(7-11)6-9(2,3)4-5-10/h8H,4-7,10-11H2,1-3H3 |
InChI Key | DPQHRXRAZHNGRU-UHFFFAOYSA-N |
Canonical SMILES | CC(CC(C)(C)CCN)CN |
Molecular Formula | C9H22N2 |
Wikipedia | 2,4,4-trimethyl-1,6-hexanediamine |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 158.289 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Complexity | 99.7 |
CACTVS Substructure Key Fingerprint | A A A D c e B z A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A H A A Q A A A A D w D B A A Q C A A B A A A A A A A A A A A A A A A A A A A A A A I A A A A A A A A I A g A A A A A A A E A A A A A E Q A A A P A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 52.0 |
Monoisotopic Mass | 158.178 |
Exact Mass | 158.178 |
XLogP3 | None |
XLogP3-AA | 1.0 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9024 |
Human Intestinal Absorption | HIA+ | 0.9411 |
Caco-2 Permeability | Caco2+ | 0.6410 |
P-glycoprotein Substrate | Substrate | 0.6849 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8673 |
Non-inhibitor | 0.5726 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7005 |
Distribution | ||
Subcellular localization | Lysosome | 0.9282 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8822 |
CYP450 2D6 Substrate | Non-substrate | 0.5873 |
CYP450 3A4 Substrate | Non-substrate | 0.6630 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8878 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8913 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8296 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8704 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8924 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9468 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9503 |
Non-inhibitor | 0.6735 | |
AMES Toxicity | Non AMES toxic | 0.9406 |
Carcinogens | Carcinogens | 0.5287 |
Fish Toxicity | High FHMT | 0.7624 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9752 |
Honey Bee Toxicity | Low HBT | 0.5701 |
Biodegradation | Not ready biodegradable | 0.9321 |
Acute Oral Toxicity | III | 0.8385 |
Carcinogenicity (Three-class) | Non-required | 0.6445 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.2425 | LogS |
Caco-2 Permeability | 0.9125 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.3678 | LD50, mol/kg |
Fish Toxicity | 1.4714 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.2838 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic nitrogen compounds |
Class | Organonitrogen compounds |
Subclass | Amines |
Intermediate Tree Nodes | Primary amines |
Direct Parent | Monoalkylamines |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Organopnictogen compound - Hydrocarbon derivative - Primary aliphatic amine - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing an primary aliphatic amine group. |
From ClassyFire